Other languages NeuroOne Medical Technologies Corporation Other OTC

Equities

NMTC

US64130M1009

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeuroOne Medical Files Shelf Registration For $150 Million Securities Offering	01/06
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	15/05
NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System	26/03
NeuroOne Medical Technologies Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	14/02
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Full Year Ended September 30, 2023	15/12
NeuroOne Gets FDA Clearance to Market OneRF Ablation System; Shares Fall	11/12
NeuroOne Medical Technologies Corporation Receives FDA 510(K) Clearance to Market its OneRF(TM) Ablation System	11/12
NeuroOne Medical Technologies Gets Notice of Allowance for Drug Delivery Patent	16/11
NeuroOne Medical Technologies Corporation Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe	16/11
NeuroOne Medical Technologies Names Christopher Volker as Chief Operating Officer	15/11
NeuroOne Medical Technologies Corporation Appoints Christopher R. Volker as Chief Operating Officer	15/11
NeuroOne Medical Technologies Corporation Provides Progress Update on FDA 510(k) Submission for OneRF?? Ablation System	07/11
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	15/23/15
Top Midday Decliners	25/23/25
Top Premarket Decliners	25/23/25
NeuroOne Medical Technologies Proposes Common Stock Offering -- Shares Sink Premarket	25/23/25
NeuroOne Medical Technologies Corporation Submits 510(K) Application to FDA for OneRF™ Ablation System	12/23/12
NeuroOne Medical Technologies Corporation Announces First Clinical Case Using Evo® sEEG Electrode in Robotic Neurosurgery	17/23/17
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	12/23/12
Top Premarket Gainers	12/23/12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NeuroOne Medical Technologies Corporation Other OTC

Equities

NMTC

US64130M1009

Other languages

Filters